Literature DB >> 10323256

Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.

S Nikolaus1, J P Huston, R U Hasenöhrl.   

Abstract

The neurokinin substance P has reinforcing effects when administered into the nucleus basalis of the rat's ventral pallidum and these effects are encoded by its carboxy-terminal amino acid sequence. The present study examined the effect of prior treatment with the tachykinin NK1 receptor antagonist WIN51,708 on the conditioned place preference produced by intrabasalis injection of substance P and its carboxy-terminal heptapeptide analog dimethyl-C7. Pretreatment with WIN51,708 (10 and 20 mg/kg, i.p.) dose-dependently reversed the place preference produced by intrabasalis substance P (0.74 pmol). The carboxy-terminal analog dimethyl-C7 (0.74 pmol) was also found to act as a reinforcer following injection into the nucleus basalis region, but unlike for substance P, the behavioral effects of dimethyl-C7 could not be completely antagonized by joint administration of the NK1 antagonist. When injected alone, WIN51,708 did not influence the preference behavior. These findings suggest that the reinforcing effects of substance P in the nucleus basalis region might be mediated via NK receptive sites. The failure of WIN51,708 to completely antagonize the behavioral effects of dimethyl-C7 is interesting in the light of evidence, indicating that the carboxy-terminal substance P analog shows higher affinity for the tachykinin NK3 than for the NK1 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323256     DOI: 10.1016/s0014-2999(99)00105-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.

Authors:  S V Nikolaev; A A Lebedev; E R Bychkov; A V Oblyapin; S A Dambinova; P D Shabanov
Journal:  Neurosci Behav Physiol       Date:  2004-09

4.  Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding.

Authors:  Andrew Rong Song Tzeng Yang; Heon Soo Yi; Jacek Mamczarz; Harry L June; Bang H Hwang; Harry L June
Journal:  Synapse       Date:  2009-11       Impact factor: 2.562

Review 5.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

6.  Cocaine and amphetamine-regulated transcript-containing neurons in the nucleus accumbens project to the ventral pallidum in the rat and may inhibit cocaine-induced locomotion.

Authors:  G W Hubert; D F Manvich; M J Kuhar
Journal:  Neuroscience       Date:  2009-10-12       Impact factor: 3.590

Review 7.  Neuronal pathways linking substance P to drug addiction and stress.

Authors:  K G Commons
Journal:  Brain Res       Date:  2009-11-11       Impact factor: 3.252

Review 8.  Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.

Authors:  Massimo Ubaldi; Nazzareno Cannella; Roberto Ciccocioppo
Journal:  Prog Brain Res       Date:  2015-11-26       Impact factor: 2.453

Review 9.  The pharmacology of neurokinin receptors in addiction: prospects for therapy.

Authors:  Alexander J Sandweiss; Todd W Vanderah
Journal:  Subst Abuse Rehabil       Date:  2015-09-07

Review 10.  Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.

Authors:  Chelsea A Vadnie; Jun Hyun Park; Noha Abdel Gawad; Ada Man Choi Ho; David J Hinton; Doo-Sup Choi
Journal:  Front Neurosci       Date:  2014-09-18       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.